User profiles for MANUEL RAMOS-CASALS

Manuel Ramos-Casals

Department of Autoimmune Diseases, ICMiD, University of Barcelona, Hospital Clinic
Verified email at clinic.cat
Cited by 50715

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

…, F Houssiau, N Caro, P Alba, M Ramos-Casals… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …

Immune-related adverse events of checkpoint inhibitors

M Ramos-Casals, JR Brahmer, MK Callahan… - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …

Adult haemophagocytic syndrome

M Ramos-Casals, P Brito-Zerón, A López-Guillermo… - The Lancet, 2014 - thelancet.com
Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of
causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ …

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

G Ruiz-Irastorza, M Ramos-Casals… - Annals of the …, 2010 - ard.bmj.com
Background: Antimalarial drugs (AMs), chloroquine (CQ) and hydroxychloroquine (HCQ), are
frequently withdrawn in patients with lupus with either severe or remitting disease. However…

Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases

M Ramos-Casals, P Brito-Zerón, S Muñoz, N Soria… - Medicine, 2007 - journals.lww.com
Tumor necrosis factor (TNF)-targeted therapies are increasingly used for a rapidly
expanding number of rheumatic and autoimmune diseases. With this use and longer follow-up …

Sjögren syndrome

…, E Theander, A Tzioufas, M Ramos-Casals - Nature reviews Disease …, 2016 - nature.com
Sjögren syndrome (SjS) is a systemic autoimmune disease that primarily affects the exocrine
glands (mainly the salivary and lacrimal glands) and results in the severe dryness of …

The cryoglobulinaemias

M Ramos-Casals, JH Stone, MC Cid, X Bosch - The Lancet, 2012 - thelancet.com
Cryoglobulins are immunoglobulins that precipitate in vitro at temperatures less than 37C
and produce organ damage through two main pathways: vascular sludging (hyperviscosity …

Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients

M Ramos-Casals, R Solans, J Rosas, MT Camps, A Gil… - Medicine, 2008 - journals.lww.com
We conducted the current study to characterize the clinical presentation of primary Sjögren
syndrome (SS) in a large cohort of Spanish patients and to determine whether epidemiologic, …

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) …

…, C Aranow, M Mackay, M Ramos-Casals… - Annals of the …, 2015 - ard.bmj.com
Background and aims We studied damage accrual and factors determining development
and progression of damage in an international cohort of systemic lupus erythematosus (SLE) …

Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients

M García-Carrasco, M Ramos-Casals, J Rosas… - Medicine, 2002 - journals.lww.com
Sjögren syndrome (SS) is a systemic autoimmune disease that mainly affects the exocrine
glands and usually presents as persistent dryness of the mouth and eyes due to functional …